Betacyanin for Early Diagnosis and Recovery of Anastomotic Leakage After Rectal Cancer Surgery: A Single-Center, Prospective, Controlled Trial

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorSouthwest Hospital, China

About this trial

This single-center, prospective, controlled trial compares betacyanin versus conventional methods for early diagnosis and healing assessment of anastomotic leakage after rectal cancer surgery.

Eligibility criteria

Qualifiers

Pathologically confirmed rectal adenocarcinoma prior to surgery.

Undergoing laparoscopic anterior resection for rectal cancer.

No prophylactic diverting ileostomy.

American Society of Anesthesiologists (ASA) Physical Status Classification ≤ 3.

Disqualifiers

Prior abdominal surgery with severe intra-abdominal adhesions.

Currently participating in, or having participated within the past 6 months in, another clinical study related to rectal cancer surgery.

Preoperative complications requiring emergency surgery, including bleeding, perforation, or obstruction.

History of prior malignancy.

Trial design

Treatments tested in this trial

  • Betacyanin
  • Pelvic Drainage Fluid Betacyanin Assay

Treatment groups

120 Participants
are divided into 1 treatment group

Sponsors and collaborators